Bibliography
- Ribozyme, Inc. (1998). Ribozyme Pharmaceuticals, Inc. and Glaxo Wellcome? Genomics evaluation agree-ment. http://wwwrpi.com/press releases.
- LUDWIG J, BLASCHKE M, SPROAT B: Extending the cleavage rule for the hammerhead ribozyme: mutating adenosine151 to inosine15'1 changes the cleavage site specificity from N16.2 U16.1 H17 to N16.2 C16.1 H17 . Nucleic Acids Res. (1998) 26:2279–2285.
- Ribozyme, Inc. (1998). Ribozyme Pharmaceuticals, Inc.http://wwwrpi.comidescrip.htm.